BARDA
Ad Astra Diagnostics Severe Infection Analyzer Nabs 510(k) Clearance
The North Carolina-based firm's hematology instrument is used to identify signs of severe blood infections, blood-related cancers, and allergies.
Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test
The molecular test would detect and differentiate among influenza A/B, respiratory syncytial virus, and COVID-19 and deliver results within 25 minutes.
In Brief This Week: T2 Biosystems; Aspira Women's Health; VolitionRx; ATCC; BARDA; Devyser
News items for the week of June 26, 2023.
Prenosis Wins $749K BARDA Contract for Sepsis Prediction Software
The company will use the funding to demonstrate the clinical value of its Sepsis ImmunoScore, an AI/machine learning-based software for predicting sepsis.
Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.